MBX Biosciences, Inc. (MBX)

MBX Biosciences, Inc. (MBX) is a healthcare company (biotechnology) based in the United States. The share price is $51.54, down 2.97% on the day, which values the company at $2.56B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$51.54−2.97% today
Market value
$2.56B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

MBX Biosciences, Inc. in more detail

MBX trades at -11.8× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Debt is growing faster than cash flow.

1 of the superinvestors tracked here hold MBX, including Polen Capital team (0.0% of the portfolio).

Superinvestors holding MBX

1 of the investors tracked here report a position in their latest 13F filing.

MBX Biosciences, Inc. (MBX): questions and answers

What is MBX Biosciences, Inc.'s market cap?

MBX Biosciences, Inc. is valued at $2.56B at a share price of $51.54.

Does MBX pay a dividend?

MBX Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own MBX?

In their latest quarterly filings, Polen Capital team (0.0% of the portfolio) hold MBX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “MBX Biosciences, Inc. (MBX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MBX

Underlying data: Yahoo Finance; company filings with the SEC.